Biologics May Lower Cardiovascular Risk in Patients With RA

The use of bDMARDs in patients with RA may have additional beneficial effects on arterial wall inflammation, independent of systemic inflammation.
Medscape Medical News

source https://www.medscape.com/viewarticle/biologic-drugs-may-mitigate-cardiovascular-event-risks-2024a1000epd?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?